Headquartered in Irvine, California, Beta Bionics, Inc. has emerged as a 
leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Beta Bionics, Inc. has developed the iLet Bionic Pancreas - a fully autonomous insulin dosing system driven by adaptive closed-loop algorithms. The iLet determines and doses 100% of the insulin doses, allowing the user to focus less on their diabetes and more on their lives.